NanoGroup S.A. (WSE:NNG)

Poland flag Poland · Delayed Price · Currency is PLN
2.625
+0.015 (0.57%)
Feb 4, 2026, 5:00 PM CET
-14.50%
Market Cap86.18M -6.0%
Revenue (ttm)-6.90K +4.0%
Net Income-6.93M
EPS-0.19
Shares Out32.83M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume83,560
Average Volume129,558
Open2.625
Previous Close2.610
Day's Range2.625 - 2.650
52-Week Range2.250 - 3.620
Beta0.72
RSI50.56
Earnings DateJan 29, 2026

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.

Financial Statements